You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb758791 |
---|---|
Category | Antibodies |
Description | Rabbit monoclonal antibody to CTLA4 |
Species/Host | Mouse |
Clonality | Monoclonal |
Clone Number | 9D9 |
Tested applications | Blocking, IF |
Reactivity | Mouse |
Isotype | IgG |
Immunogen | The antibody was raised against CTLA-4. |
Concentration | 1 mg/ml |
Purity | Purified |
Conjugation | Unconjugated |
Target | CTLA-4 |
UniProt ID | P09793 |
Storage | Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. |
Buffer/Preservatives | PBS with 0.02% Proclin 300. |
Alternative names | CD152; CTLA4; Cytotoxic T-Lymphocyte Associated Pr Read more... |
Note | For research use only |
Application notes | The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non-irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs. |
Expiration Date | 12 months from date of receipt. |
Filter by Rating